What inspires us as a company has always been the fascinating world of science and our interests are mostly about understanding how microorganisms can be used to produce certain proteins as well as enhancing biological processes. Moreover, how these molecules and biological processes can be used for pharmaceuticals, diagnostics and food technologies development.
Key indigenous resources are hallmarks to our innovation and may enable us to develop diagnostic tools to respond to diseases outbreaks in future, both in Africa and globally.
We knew that our country relies heavily on imported diagnostic kits and other technologies used in Life Sciences field. We positioned our company to respond to the need for local products – especially during a crisis like COVID-19. Before the pandemic, we were selling our products in both South Africa and United States of America – as reagents for research and development. Before the rapid spread of the virus, we decided to use some of our existing technologies, proprietary formulations and processes to develop a COVID-19 test kit that can be distributed across the continent. CapeBio has now developed a rapid COVID-19 PCR testing kit with unique biologics and reagents developed in South Africa.